PLA2G16 Polyclonal Antibody

Elabscience
Product Code: E-AB-91401
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-91401-60uL60uL£210.00
Quantity:
E-AB-91401-120uL120uL£291.00
Quantity:
E-AB-91401-200uL200uL£431.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Application: Western Blot (WB)
Shipping:
Ice packs
Storage:
Store at -20°C. Avoid freeze/thaw cycles.

Images

1 / 1
Western blot analysis of extracts of various cell lines using PLA2G16 Polyclonal Antibody at 1:1000 dilution.

Western blot analysis of extracts of various cell lines using PLA2G16 Polyclonal Antibody at 1:1000 dilution.

Documents

Further Information

Abbreviation:
PLA2G16
Background:
Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1 and A2 (PLA2 activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE, forming N-acylphosphatidylethanolamine (NAPE, which serves as precursor for N-acylethanolamines (NAEs. Exhibits high N-acyltransferase activity and low phospholipase A1/2 activity. Required for complete organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light. Organelle membrane degradation is probably catalyzed by the phospholipase activity (By similarity.
Buffer:
PBS with 0.01% thiomersal,50% glycerol,pH7.3.
Calculated MW:
18kDa
Concentration:
1mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000
Immunogen:
Recombinant fusion protein of human PLA2G16
ObservedMW:
18kDa
Purification method:
Affinity purification
Target Synonym:
PLA2G16;AdPLA;H-REV107;H-REV107-1;HRASLS3;HREV107;HREV107-1;HREV107-3;HRSL3
UNIProt ID:
P53816